Surgery for advanced gastric cancer

The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis, and Therapy

Volumn , Issue , 2005, Pages 271-286

  Mafune, Ken Ichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65449187219     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/4-431-27713-7_20     Document Type: Chapter

References (51)

1. Maruyama K, Sasako M, Kinoshita T, et al (1993) Effectiveness of systematic lymph node dissection in gastric surgery. In: Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E (eds). Gastric cancer. Springer, Berlin, pp 293-305
2. Akoh JA, Macintyre IM (1992) Improving survival in gastric cancer review of 5-year survival rates in English publications from 1970. Br J Surg 79:293-299
3. Wanebo HJ, Kennedy BJ, Chmiel J, et al (1993) Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 218:583-592
4. Japanese Gastric Cancer Association, Registration Committee (2003) Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 6(suppl): 1-14
5. Bunt A, Herman J, Smit V, et al (1995) Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rate between Japan and Western countries. J Clin Oncol 13:19-25
6. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333:32-41
7. Diggory MT, Cuschieri A (1985) R2/3 gastrectomy for gastric carcinoma: an audited experience of a consecutive series. Br J Surg 72:146-148
8. Dent DM, Madden MV, Price SK (1988) Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 75:110-112
9. Pacelli F, Doglietto GB, Bellantone R, et al (1993) Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 80:1153-1156
10. Siewert JR, Bottcher K, Roder JD, et al (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 80: 1015-1018
11. Bonenkamp JJ, Hermans J, Sasako M, et al (1999) Extended lymph node dissection for gastric cancer. N Engl J Med 340:908-914
12. Cuschieri A, Weeden S, Fielding J, et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 79:1522-1530
13. Schmidt-Matthiesen A (1998) Should systematic lymph node dissection be recommended for gastric cancer? Contra. Eur J Cancer 34:1483-1486
14. Sasako M (2004) Role of surgery in multidisciplinary treatment for solid cancers. Int J Clin Oncol 9:346-351
15. Bonenkamp JJ, Songun I, Hermans J, et al (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345:745-748
16. Cuschieri A, Fayers P, Fielding J, et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 347:995-999
17. Sano T, Sasako M, Yamamoto S, et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767-2773
18. Moriwaki Y, Kunisaki C, Kobayashi S, et al (2003) Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogas-troenterology 50:284-288
19. Gretschel S, Christoph F, Bembenek A, et al (2003) Body mass index does not affect systematic D2 lymph node dissection and post operative morbidity in gastric cancer patients. Ann Surg Oncol 10:363-368
20. Sasako M, McCulloch P, Kinoshita T, et al (1995) New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82:346-351
21. Siewert JR, Bottcher K, Stein HJ, et al (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449-461
22. Kooby DA, Suriawinata A, Klimstara DS, et al (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237:828-837
23. Maruyama K, Sasako M, Kinishita T, et al (1998) Should systemic lymph node dissection be recommended for gastric cancer? pro. Eur J Cancer 34:1480-1483
24. Kasakura Y, Mochizuki F, Wakabayashi K, et al (2002) An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res 103:252-259
25. Roukos DH, Lorenz M, Encke A (1998) Evidence of survival benefit of extended (D2) lym-phadenectomy in Western patients with gastric cancer based on a new concept. A prospective long-term follow-up study. Surgery (St. Louis) 123:573-578
26. Harrison LE, Karpeh MS, Brennan MF (1998) Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 2:126-131
27. Smith JW, Shiu MH, Kelsey L, et al (1991) Morbidity of radical lymphadenectomy in curative resection of gastric carcinoma. Arch Surg 126:1469-1473
28. Sue-Ling HM, Johnston D, Martin IG, et al (1993) Gastric cancer: a curable disease in Britain. Br J Surg 307:591-596
29. Birkmeyer JD, Stukel TA, Siewers AE, et al (2003) Surgeon volume and operative mortality in the United States. New Engl J Med 349:2117-2127
30. Fujita T, Yamazaki Y (2002) Influence of surgeon's volume on early outcome after total gastrectomy. Eur J Surg 168:535-538
31. Perikh D, Johnson M, Chagla L, et al (1996) D2 gastrectomy lessons from a prospective audit of the learning curve. Br J Surg 83:1595-1599
32. Moriwaki Y, Kobayashi S, Kunisaki C, et al (2001) Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator? Dig Surg 18:111-117
33. Degiuli M, Sasako M, Ponti A, et al (1998) Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 16(4):1490-1493
34. Degiuli M, Sasako M, Ponti A, et al (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90(9):1727-1732
35. Takahashi S (1990) Study of para-aortic lymph node metastases of gastric cancer subjected to superextensive lymph node dissection (in Japanese with English abstract). J Jpn Surg Soc (Nippon Geka Gakkai Zasshi) 91:29-35
36. Kitamura M, Arai K, Iwasaki Y (1996) Clinicopathological studies and problems on paraaortic lymph node dissection: D4 dissection (in Japanese with English abstract). J Jpn Surg Soc (Nippon Geka Gakkai Zasshi) 97:302-307
37. Isozaki H, Okajima K, Fujii K, et al (1999) Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 46:549-554
38. Baba M, Hokita S, Natsugoe S, et al (1999) Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterology 47:893-896
39. Ohashi I, Takagi K, Konishi T, et al (1976) Five-year survival of patients with dissection of paraaortic lymph node metastases for gastric cancer (in Japanese with English abstract). Jpn J Gastroenterol Surg 9:112-116
40. Yonemura Y, Hashimoto T, Katayama K, et al (1985) Classification of paraaortic lymph nodes and significance of dissection of these nodes in gastric cancer (in Japanese with English abstract). Jpn J Gastroenterol Surg 18:1995-1999
41. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1:10-24
42. Sano T, Sasako M, Yamamoto S, et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended paraaortic lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol 22: 2767-2773
43. Shimoyama S, Mafune K, Kaminishi M (2005) Safety of a paraaortic node dissection for selected advanced gastric cancer patients. Hepatogastnoenterology (in press)
44. Maeta M, Yamashiro H, Saito H, et al (1999) A prospective pilot study of extended (D3) and super extended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery (St. Louis) 125:325-331
45. Appleby LH (1953) The celiac axis in the expansion of the operation for gastric carcinoma. Cancer (Phila) 6:704-707
46. Takagi K (1990) Extended operation (in Japanese). Gastroenterol Surg 13:789
47. Hiratsuka M, Furukawa H (2003) Application of left upper abdominal extentration. In: Arai K (ed) Knack and pitfalls of gastric surgery (in Japanese). Bunkodo, Tokyo, pp 109-111
48. Furukawa H, Hiratsuka M, Iwanaga T, et al (1997) Extended surgery-left upper abdominal extenteration plus Appleby's method-for type 4 gastric carcinoma. Ann Surg Oncol 4: 209-214
49. Hulscher JB, van Sandick JW, de Boer AG, et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662-1669
50. Sasako M, Sano T, Sairenji M, et al (2004) Left thorac-abdomonal approach (LT) compared with abdominal and transhiatal approach (AT) for cardia or sub-cardia cancer. Results of a surgical randomized controlled trial (JCOG 9502). J Clin Oncol 22:314s
51. Oyama S, Yamaguchi T (2003) Application of pancreatoduodenectomy. In: Arai K (ed) Knack and pitfalls of gastric surgery (in Japanese). Bunkodo, Tokyo, pp 112-115